Nomura Asset Management Co. Ltd. Reduces Stock Holdings in Cardinal Health, Inc. $CAH

Nomura Asset Management Co. Ltd. decreased its position in Cardinal Health, Inc. (NYSE:CAH) by 7.3% during the 4th quarter, Holdings Channel.com reports. The firm owned 315,873 shares of the company’s stock after selling 24,956 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Cardinal Health were worth $64,912,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. lifted its stake in Cardinal Health by 2.0% in the fourth quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock valued at $6,461,179,000 after purchasing an additional 617,775 shares during the last quarter. Geode Capital Management LLC lifted its stake in Cardinal Health by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company’s stock valued at $1,336,750,000 after purchasing an additional 43,924 shares during the last quarter. Wellington Management Group LLP lifted its stake in Cardinal Health by 153.2% in the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after purchasing an additional 3,511,579 shares during the last quarter. Norges Bank purchased a new position in Cardinal Health in the fourth quarter valued at approximately $790,344,000. Finally, Bank of America Corp DE lifted its stake in Cardinal Health by 3.2% in the third quarter. Bank of America Corp DE now owns 3,592,775 shares of the company’s stock valued at $563,922,000 after purchasing an additional 111,582 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. Barclays upped their price objective on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, February 24th. Argus upped their price objective on Cardinal Health from $232.00 to $248.00 and gave the company a “buy” rating in a research note on Wednesday, February 11th. Wells Fargo & Company dropped their price objective on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. William Blair assumed coverage on Cardinal Health in a research note on Tuesday, April 28th. They issued an “outperform” rating on the stock. Finally, JPMorgan Chase & Co. dropped their price objective on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research note on Monday, May 4th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $241.80.

Cardinal Health Price Performance

NYSE:CAH opened at $196.57 on Monday. The company has a market cap of $46.04 billion, a P/E ratio of 30.06, a P/E/G ratio of 1.17 and a beta of 0.52. The stock’s fifty day moving average price is $203.52 and its two-hundred day moving average price is $208.81. Cardinal Health, Inc. has a 1 year low of $137.75 and a 1 year high of $233.60.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, analysts expect that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s dividend payout ratio (DPR) is currently 31.19%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.